The company said its Q3 2024 (3 months) revenue was $543.9 million, up 25.7% from $432.7 million a year earlier, or 25.4% in constant currency.

1. 01

   The company said its Q3 2024 (3 months) revenue was $543.9 million, up 25.7% from $432.7 million a year earlier, or 25.4% in constant currency.

2. 02

   Insulet reported gross margin of 69.3% for Q3 2024 (67.8% a year earlier), operating income of $88.1 million ($54.8 million a year earlier), and net income of $77.5 million, or $1.08 per diluted share.

3. 03

   The company said its adjusted net income for Q3 was $64.2 million, or $0.90 per diluted share, excluding a tax benefit of $14.8 million, mainly from the release of the valuation allowance, and an investment loss of $1.5 million.

4. 04

   The company raised its constant-currency revenue growth outlook for 2024 to 20% to 21% from 16% to 19%, and said it now expects an operating margin of about 14.5%, up 50 basis points.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.